The White House decision to tap Francis S. Collins as the president’s acting science adviser signals the administration’s priorities in advancing biomedical research and gives the recently retired NIH chief more influence to pick his successor.
Biden announced two appointments to fill the roles held by Eric Lander, who resigned this month as science adviser and director of the Office of Science and Technology Policy after findings that he bullied subordinates and created a hostile work environment.
Collins, 71, who retired in December after more than a dozen years leading the National Institutes of Health, will become the acting science ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.